DMBT1 Protein (AA 2008-2413) (His tag)

N° du produit ABIN7399658

Détail du produit

Antigène: DMBT1 (Deleted in Malignant Brain Tumors 1 (DMBT1))

Type de proteíne: Recombinant

Attributs du protein: AA 2008-2413

Origine: Humain

Source: Escherichia coli (E. coli)

Purification/Conjugué: Cette DMBT1 protéine est marqué à la His tag.

Application: Western Blotting (WB), SDS-PAGE (SDS), Immunogen (Imm), Positive Control (PC)

Séquence: Cys2008-Arg2413

Attributs du produit: Recombinant Deleted In Malignant Brain Tumors 1 (DMBT1), Prokaryotic expression, Cys2008-Arg2413, N-terminal His Tag

Pureté: > 95 %

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Commentaires:

Isoelectric Point:6.7

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Buffer: 20 mM Tris, 150 mM NaCl, pH 8.0, containing 1 mM EDTA, 1 mM DTT, 0.01 % SKL, 5 % Trehalose and Proclin300.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-80 °C

Stockage commentaire: Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Date de péremption: 12 months

Détail du antigène

Antigène: DMBT1 (Deleted in Malignant Brain Tumors 1 (DMBT1))

Autre désignation: Deleted In Malignant Brain Tumors 1 (DMBT1 Produits)

Synonymes: GP340 Protein, muclin Protein, CRP Protein, CRP-[a] Protein, CRP-[b] Protein, Crpd Protein, DBMT1 Protein, gp300 Protein, p80 Protein, DMBT1 Protein, gp340 Protein, deleted in malignant brain tumors 1 Protein, deleted in malignant brain tumors 1 protein Protein, gp340 Protein, deleted in malignant brain tumors 1 S homeolog Protein, DMBT1 Protein, Dmbt1 Protein, LOC100064515 Protein, dmbt1 Protein, ST201phi2-1p340 Protein, dmbt1.S Protein

Sujet: GP340, SAG, Muclin, Glycoprotein 340, Hensin, Salivary agglutinin, Surfactant pulmonary-associated D-binding protein

Poids moléculaire: 50kDa

UniProt: Q9UGM3

Pathways: Activation of Innate immune Response